SCHEMBL15065752

SCHEMBL15065752

O=C(C=Cc1cc(NCc2ccccn2)ccc1Oc1cccc(Cl)c1)NO

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.46
▸ ALDH1A1 P00352 4/20 0.43
▸ KDM4E B2RXH2 3/20 0.43
▸ HDAC8 Q9BY41 4/20 0.41
▸ HDAC1 Q13547 3/20 0.41
▸ HDAC6 Q9UBN7 3/20 0.41
▸ HDAC4 P56524 7/20 0.41
▸ HDAC3 O15379 2/20 0.41
▸ HDAC7 Q8WUI4 2/20 0.41
▸ HDAC2 Q92769 2/20 0.41
▸ HDAC10 Q969S8 2/20 0.41
▸ HDAC11 Q96DB2 2/20 0.41
▸ HDAC9 Q9UKV0 2/20 0.41
▸ HDAC5 Q9UQL6 2/20 0.41
▸ MEF2D Q14814 5/20 0.41
▸ RAB9A P51151 3/20 0.40
▸ NPC1 O15118 2/20 0.40
▸ MAPT P10636 2/20 0.40
▸ HTT P42858 1/20 0.39
▸ HPGD P15428 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15088661 1.00 LMNA (0.46) LMNAALDH1A1KDM4EHDAC8HDAC1
SCHEMBL15088667 0.89 HDAC4 (0.45) ALDH1A1KDM4EHDAC8HDAC1HDAC6
SCHEMBL15065681 0.89 HDAC4 (0.45) ALDH1A1KDM4EHDAC8HDAC1HDAC6
SCHEMBL15088616 0.89 MAPT (0.45) ALDH1A1KDM4EHDAC8HDAC1HDAC6
SCHEMBL15065747 0.89 MAPT (0.45) ALDH1A1KDM4EHDAC8HDAC1HDAC6
SCHEMBL15088623 0.85 SCN9A (0.49) ALDH1A1KDM4EHDAC8HDAC1HDAC6
SCHEMBL15066348 0.85 SCN9A (0.49) ALDH1A1KDM4EHDAC8HDAC1HDAC6
SCHEMBL15066665 0.83 HDAC4 (0.52) LMNAALDH1A1HDAC8HDAC1HDAC6
SCHEMBL15088591 0.83 HDAC4 (0.52) LMNAALDH1A1HDAC8HDAC1HDAC6
SCHEMBL15065367 0.78 LMNA (0.51) LMNAALDH1A1KDM4EHDAC8HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150045367-A1 CINNAMIC ACID HYDROXYAMIDES AS INHIBITORS OF HISTONE DEACETYLASE 8 PHARMACYCLICS LLC 2015-02-12 — — US claimed
US-20150045367-A1 CINNAMIC ACID HYDROXYAMIDES AS INHIBITORS OF HISTONE DEACETYLASE 8 PHARMACYCLICS LLC 2015-02-12 — — US disclosed
EP-2797875-A1 CINNAMIC ACID HYDROXYAMIDES AS INHIBITORS OF HISTONE DEACETYLASE 8 Pharmacyclics, Inc. (US) 2014-11-05 — — EP disclosed
WO-2013101600-A1 CINNAMIC ACID HYDROXYAMIDES AS INHIBITORS OF HISTONE DEACETYLASE 8 PHARMACYCLICS, INC. (US) 2013-07-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150045367-A1 CINNAMIC ACID HYDROXYAMIDES AS INHIBITORS OF HISTONE DEACETYLASE 8 HDAC8, HDAC5, HDAC7 LMNA 537/4885ALDH1A1 688/4885KDM4E 781/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback